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p=0.001). Group B had more in-hospital complications (56% vs. 0%, p=0.001), such as
congestive heart failure, ventricular septal rupture and pericardial effusion.
Conclusions: The evaluation of LAD flow using TCDE in pts with AMI in the ER is feasi-
ble. The assessment of CBF pattern using TCDE in pts with AMI is a rapid and promising
method to predict clinical outcome, may contribute deciding the treatment strategy of
AMI.
1041-95 Sildenafil Citrate (Viagra) Induces Powerful 
Cardioprotective Effects Following Ischemia-
Reperfusion Injury in Infant Rabbits
Yvonne A. Bremer, Fadi Salloum, Ramzi Ockaili, Eric J. Chou, William B. Moskowitz, 
Rakesh C. Kukreja, Virginia Commonwealth University, Richmond, VA
Background: We recently demonstrated that sildenafil citrate, a potent phosphodi-
esterase-5 inhibitor, induces a preconditioning-like effect through synthesis of nitric oxide
and opening of mitochondrial KATP channels in adult rabbits. The purpose of this study
was to demonstrate the effects of sildenafil on myocardial functional improvement and
infarct size reduction during ischemia/reperfusion injury in infant rabbits.
Methods: 8-week-old rabbits were treated with sildenafil (0.7mg/kg IV) or saline 30 min-
utes prior to ischemia for 30 minutes and reperfusion for 3 hours. Transesophageal
echocardiography was utilized to assess left ventricular cardiac output (LVCO) and aortic
Velocity Time Integral (VTI). Sections of left ventricular myocardium were analyzed for
infarct size using triphenyltetrazolium staining and computer morphometry.
Results: The sildenafil group had significant reduction in infarct size (15.5+/-1 versus
33+/-1.5 in controls, % risk area, mean+/-SEM, n=10-15/group, p<0.05). Sildenafil
treated rabbits had a 34% decline in mean arterial pressure (MAP) and a 8% increase in
heart rate (HR) compared to controls after drug administration (p<0.05) but were compa-
rable to controls prior to ischemia. The controls had a decline in LVCO and aortic VTI
after ischemia (18% and 16% lower than baseline values, respectively, p<0.05), while the
LVCO and aortic VTI increased in the sildenafil group (20% and 15% higher than base-
line values, respectively, p<0.05). This is a statistically significant increase in LVCO and
aortic VTI in the sildenafil group compared to controls (n=6/group, p<0.05).
Conclusion: For the first time, we have shown that sildenafil citrate promotes myocardial
protection in infant rabbits as evidenced by preservation and even elevation in post-
ischemic LVCO and aortic VTI and reduction in infarct size. This may prove to be a viable
model for myocardial ischemia in pediatric cardiac surgery involving cardiopulmonary
bypass, circulatory arrest, or low flow states. As such, the mechanism of cardioprotec-
tion, either through preconditioning, enhanced inotropy, or hemodynamic effects, needs
further investigation.
1041-96 Acute Myocardial Infarction Size Determines N-Terminal 
Pro-Brain Natriuretic Peptide Release as Measured by 
Contrast Enhanced Magnetic Resonance Imaging
Thomas N. Martin, Henry Dargie, Tracey Steedman, John Foster, Alex Elliott, John 
James Morton, Bjoern Aaris Groenning, Glasgow University, Glasgow, United Kingdom
Background: Plasma N-terminal pro Brain Natriuretic Peptide (NTBNP) concentrations
are elevated post Acute Coronary Syndromes (ACS) and predict left ventricular (LV)
remodeling. It is unclear whether NTBNP release is due to myocardial necrosis or wall
stress. We assessed the relationship between NTBNP and infarct size using rest contrast
enhanced Magnetic Resonance imaging (ceMR).
Methods: 36 male and 18 female (median (range) age=61 (34-83) years index hospital
admissions with ACS (initial treatment: 24 primary thrombolysis, 30 conservative) were
consecutively recruited. Exclusions: serum creatinine >200µmol/l or history of chronic
renal failure, hypertension, cardiomyopathy, significant valve disease or cor pulmonale.
Blood sampling for troponin I (TnI) took place at 8-12 hours and for serum creatinine and
NTBNP (Elecsys 2010, Roche NTBNP assay) prior to ceMR at a median (range) of 69
(16-120) hrs. LV dimensions were evaluated by cinematographic (TrueFISP) breath-hold
sequence using a Siemens Sonata 1.5T system. ceMR was performed 10 minutes after
injection of 0.2 mmol/kg gadolinium-DTPA using a breath-hold segmented turbo FLASH
inversion-recovery sequence. Images were evaluated by planimetry by 2 blinded observ-
ers and the consensus used.
Results: Haemodynamic measures: mean (SD) heart rate 54 (11) bpm, systolic BP 122
(19) mmHg, diastolic BP 76 (12) mmHg. Renal function: creatinine 98 (22) µmol/l. Log
NTBNP (median (range 3.03 (1.9 -3.96) pg/l) strongly correlated with late enhancement
(LE) volume (mean (SD) 27 (25) ml: r=0.55, p<0.0001 but less well with TnI (median
(range) 16.2 (0.3-417) µg/ml): r=0.34, p=0.01. TnI correlated strongly with LE volume:
r=0.6, p<0.0001. Log NTBNP was unrelated to LV ejection fraction (mean (SD) 56 (10)
%), LV mass (130 (36) g), LV end diastolic (137 (35) ml) or end systolic (60 (23) ml) vol-
umes.
Conclusion: In patients with ACS the amount of myocardium damaged, assessed using
ceMR, correlates strongly with an early increase in both plasma NTBNP and TnI. The
correlation between NTBNP and TnI is not as strong suggesting that there is an addi-
tional mechanism underlying its release. There is no relationship between NTBNP and
LV function and dimensions.
1041-97 Assessment of Transmyocardial Velocity Distribution 
During High Dose Dobutamine Stress 
Echocardiography Using Myocardial Velocity Profile
Hideji Tanaka, Tomotsugu Tabata, Kenji Harada, Eriko Kimura, Akihiro Saito, Tetsuzo 
Wakatsuki, Masahiro Nomura, Susumu Ito, The University of Tokushima, Tokushima, 
Japan
Background: High dose dobutamine stress echocardiography (DSE) has been popularly
used for non-invasively detecting myocardial ischemia. Myocardial velocity profile (MVP)
obtained by color tissue Doppler imaging (TDI) can optimize instantaneous distribution of
myocardial velocity components from endocardium to epicardium.
Purpose: To assess the changes in transmyocardial velocity distribution during high
dose DSE from an analysis of MVP.
Methods: Eighteen patients with chest pain suspected to have coronary artery disease
by stress scintigraphy (99mTc-MIBI) were recruited for high dose DSE. Color TDI was
recorded from parasternal short-axis view during DSE, and MVP was analyzed off-line.
Results: 1) In the region of perfusion defect by scintigraphy, the MVP at rest showed lin-
ear myocardial velocity distribution from endcardium to epicardium with the highest
velocity at endocardium. 2) During high dose DSE, the peak systolic velocities at suben-
docardial region significantly decreased (3.99 vs 1.49 cm/s, p<0.001) resulting in the
decrease in the slope of the linear regression line (myocardial velocity gradient)( 5.01 vs
0.90 s-1, p<0.001)
Conclusions: MVP obtained by color TDI clearly demonstrated changes in transmyocar-
dial velocity distribution during DSE. Deterioration of the myocardial contractility in
ischemic region by high dose DSE can be precisely evaluated by observing decrease in
myocardial velocity gradient reflecting decrease in subendocardial velocities.
1041-98 Epigallocatechin-3-Gallate Inhibits Stat-1 Activation and 
Protects Cardiac Myocytes From Ischemia/
Reperfusion–Induced Apoptosis
Anastasis Stephanou, Carol Chen-Scarabelli, David Latchman, Julius Gardin, Jagat 
Narula, Tiziano Scarabelli, Institute of Child Health, University College London, London, 
United Kingdom, St John Hospital, Wayne State University, Detroit, MI
Objectives. This study was aimed at evaluating the protective effects of epigallocat-
echin-3-gallate (EGCG) and green tea extract (GTE) on primary cultures of cardiac myo-
cytes and the isolated rat heart respectively.
Background. We have previously demonstrated that STAT-1 plays a critical role in pro-
moting apoptotic cell death in cardiac myocytes following ischemia/reperfusion (I/R)
injury. EGCG, the major constituent of green tea, has recently been reported to inhibit
STAT-1 activity in non-cardiac cells.
Methods and Results. Treatment of cardiac myocytes with 1µg/ml of EGCG 4 hours
before simulated I/R (4 hours of hypoxia, followed by 16 hours of reoxygenation) reduced
STAT-1 phosphorylation and provided protection against I/R-induced apoptotic cell death
(annexin V and propidium iodide staining, followed by flow cytometer assessment)
(p<0.01). Moreover, EGCG reduced the expression of pro-apoptotic Fas receptor and
decreased Fas promoter activity, a known STAT-1 pro-apoptotic target gene. More inter-
estingly, a freshly prepared solution of 0.1% GTE, supplied every day to treated animals,
as the sole source of drinking water, over a period of 7 consecutive days, limited the
extent of infarct size (25.4±1.7 vs 37±2.3% of I/R controls; p<0.05), and attenuated the
magnitude of myocyte apoptosis (colocalization of TUNEL and cleaved caspase-3)
(4.1±0.6 vs 7.1±1.4 of I/R controls; p<0.05), in the isolated rat heart exposed to 35 mins
of regional I, followed by 2 hours R. Importantly, the lessening in necrotic and apoptotic
cell death was associated with improved hemodynamic recovery and ventricular function
in the ischemic/reperfused rat heart (p<0.05).
Conclusions. This is the first report showing that consumption of green tea is able to
mediate cardioprotection and enhance cardiac function during I/R injury. Since GTE-
mediated cardioprotection is achieved, at least in part, through inhibition of STAT-1 activ-
ity, we may postulate that a similar action can be implemented in the clinical setting, to
minimize STAT-1 activation levels in patients with acute coronary artery disease (CAD).
1041-99 Mild Local Hypothermia Preserves High Energy 
Phosphate Metabolism During Regional Ischemia
Boris Z. Simkhovich, Sharon L. Hale, Robert A. Kloner, Good Samaritan Hospital, Los 
Angeles, CA
Background: Recently we showed that mild topical hypothermia without a cardioplegic
component significantly decreased infarct size (by up to 65%) in the in vivo rabbit heart
model of regional ischemia. The mechanism for this marked effect remains to be deter-
mined. We hypothesized that this cardioprotection was due to preservation of high
energy phosphates.
Methods: The circumflex coronary artery (or a major branch) was isolated with a 4-O silk
suture in anesthetized, opened-chest rabbits. Rabbits were randomized to: ischemic
hypothermia (IH, n=10), or ischemic normothermia (IN, n=10) groups. In the IH group
regional mild myocardial hypothermia (~32ºC) was initiated by placing an ice-water bag
directly on the surface of the heart corresponding to the risk zone 15 min prior to the
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onset of sustained ischemia, and was maintained for the duration of 20 min of coronary
occlusion. The IN group received 15 min of waiting period followed by 20 min of ischemia.
The ischemic and the non-ischemic tissues in the IN and IH hearts were separated and
processed for tissue adenosine triphosphate (ATP), creatine phosphate (CP), lactate and
glycogen determination.
Results: Ischemia decreased ATP, CP and glycogen content (by 67%, 73% and 73%
respectively) and caused 13-fold accumulation of lactate in the ischemic vs. the non-
ischemic area in the IN hearts. However, mild, regional hypothermia preserved ATP and
glycogen stores in the ischemic area of IH rabbits by 43% and 83% respectively (i.e.
1.20±0.11 µmol/g in the IH vs. 0.84±0.06 µmol/g in the IN group, p<0.05 for ATP; and
1.32±0.15 mg/g in the IH vs. 0.72±0.07 mg/g in the IN group, p<0.05 for glycogen). In
addition, mild regional hypothermia caused a trend towards the preservation of CP by
14% in the ischemic tissue (0.81±0.15 µmol/g in the IH group vs. 0.71±0.07 µmol/g in the
IN group).
Conclusion: It is likely that the mechanism whereby mild regional hypothermia reduces
infarct size is by slowing the metabolism of the crucial high energy phosphate, ATP. This
is the first study to show that in a model of regional ischemia local therapy with very mild
reductions in myocardial temperature preserves ATP within the ischemic risk zone.
1041-100 Hydrochlorothiazide Further Improves Survival During 
Angiotensin-Converting Enzyme Inhibitor Therapy After 
Experimental Myocardial Infarction
Bart Westendorp, Regien G. Schoemaker, Hendrik Buikema, Wiek H. van Gilst, Dirk J. 
van Veldhuisen, University of Groningen, Groningen, The Netherlands, University 
hospital of Groningen, Groningen, The Netherlands
Background: Efficacy of ACE inhibitor (ACEi) treatment after myocardial infarction may
be positively influenced by concomitant sodium depletion with diuretics, as is reported in
treatment of renal proteinuric disease and hypertension.
Hypothesis: Treatment with the diuretic hydrochlorothiazide (HCT) augments beneficial
effects of chronic ACEi treatment after MI.
Methods: Rats were subjected to coronary ligation to induce MI. After 2 weeks, rats were
randomized to 15 mg/kg/day quinapril only (QUI, n=44), or 50 mg/kg/day HCT in addition
to quinapril (QUI-HCT, n=46). Survival was checked for 62 weeks. LV function and neuro-
hormones were measured in survivors after 62 weeks and in a separate batch of rats
treated for 35 weeks according to the same procedures (QUI, n=6; QUI-HCT, n=5).
Results: Results are shown in the table. Until week 35 survival was significantly
improved by additional HCT (p<0.05). Urinary protein excretion and left ventricular end-
diastolic pressures (LVEDP) were decreased in QUI-HCT rats at week 35. Plasma renin
activity (PRA) was lower in QUI-HCT rats at 35 weeks. After 62 weeks, differences had
waned off.
Conclusion: Adding of HCT to QUI treatment further improved survival, neurohumoral
status, and proteinuria during the early chronic phase of experimental post-MI LV dys-
function. The results suggest that combined therapy with diuretics and ACEi can be a
safe treatment to improve prognosis of post-MI LV dysfunction.
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1042-77 Haptoglobin Polymorphism Is Associated With Short-
Term Mortality and Heart Failure in Patients With 
Diabetes and Acute Myocardial Infarction
Mahmoud Suleiman, Doron Aronson, Michael Kapeliovich, Walter Markiewicz, Haim 
Hammerman, Shimon A. Reisner, Rachel Lotan, Michael Shochat, Nina S. Levy, Andrew 
P. Levy, Rambam, Haifa, Israel
Introduction: Patients (pts) with diabetes presenting with acute myocardial infarction
(AMI) have a poor in-hospital outcome primarily due to an increased incidence of death
and heart failure. The susceptibility to diabetic complications is partially determined by
genetic factors. Haptoglobin (Hp) phenotype is related to the risk of developing both
microvascular and macrovascular complications of diabetes. We prospectively tested the
hypothesis that Hp phenotype is related to the outcome of pts with diabetes presenting
with AMI.
Methods: We enrolled 798 consecutive pts with AMI. The primary endpoint was 30-days
mortality or heart failure. Infarct size was determined by echocardiography on day 2-3.
Multivariate logistic regression was used to calculate adjusted ORs and to test for inter-
action between Hp phenotype and diabetes with respect to the primary endpoint.
Results: At 30-days, 237 patients (29.7%) died or developed heart failure. Multivariate
logistic regression identified a strong protective effect of Hp 1-1 phenotype with regard to
the primary endpoint of 30-days mortality or heart failure (OR for Hp 1-1 versus Hp 2-1 or
Hp 2-2: 0.43; 95% CI 0.22-0.84, P = 0.01). The interaction between Hp phenotype and
diabetes was highly significant in unadjusted (P = 0.008) and adjusted (P = 0.005) logis-
tic regression models. In a stratified analyses, Hp 1-1 phenotype was not related to out-
come among pts without diabetes (Adjusted OR 0.78; 95% CI 0.33-1.82, P = 0.56). By
contrast, Hp 1-1 phenotype was associated with a strong protective effect with regard to
the primary endpoint among pts with diabetes (Adjusted OR 0.21; 95% CI 0.07-0.62, P =
0.005). Among pts with diabetes, Hp 1-1 was also associated with a smaller infarct size
compared with Hp 2-1/2-2 (echocardiographic wall motion score index 1.70 ± 0.03 vs
1.45 ± 0.07, P = 0.005), whereas in pts without diabetes there was no significant differ-
ence. Conclusion: Hp phenotype may be an important genetic marker that affects the
outcome of patients with diabetes and AMI. Better understanding of the mechanism
underlying Hp effect may help to reduce morbidity and mortality in patients with diabetes
in the setting of AMI.
1042-78 Does Chronic Infection With Chlamydia Pneumoniae 
Influence the Prognosis of Acute Coronary Syndromes? 
Insights From a Nested Matched Case-Control 
Substudy of the GUSTO IV Acute Coronary Syndromes 
Trial
Cynthia M. Westerhout, Judy Gnarpe, Wei-Ching Chang, Elliot S. Barnathan, Eric 
Boersma, Stefan James, Robert M. Califf, Maarten L. Simoons, Paul W. Armstrong, 
University of Alberta, Edmonton, Canada
Background: Prior studies of chronic Chlamydia pneumoniae(Cpn) infection and
adverse outcomes of ACS are inconclusive, small in sample size and used non-standard-
ized antibody detection methods. Thus, in well-defined non-ST-elevation(NSTE) ACS pts
followed for 1yr, serologically defined chronic Cpn infection may be a significant predictor
of adverse outcomes. Methods: This case-control substudy of GUSTO-IV ACS (n=7800)
randomly selected 295 pts who had 30-day(30d) death or myocardial infarction
(MI)(cases) (with 90% power). Cases were matched to 295 controls on age, sex, CK-MB
and smoking status(potential confounder of Cpn infection). Cpn IgG and IgA titers were
measured in baseline serum with microimmunofluorescence technique. Conditional
logistic regression identified predictors of 30d death/MI and 1yr death. Results: Controls
were similar to cases in Cpn IgG >=1:32 (85% v 80% p>0.1) and IgA >=1:16 (43% v 49%
p=0.07). After baseline adjustment, troponin T was a significant predictor of 30d death/
MI, but CRP, IgG and IgA were not. Given the value of long-term prognosis, a subset was
drawn from 590-pt cohort:138 pts who died at 1y plus its partner in the existing matched
pair who survived 1y(n=276). Pts with IgG>=1:256 were at twice the risk of 1y death and
was independent of CRP, also a significant predictor of 1y death(Figure). Conclusions:
Whereas chronic Cpn infection was not associated with 30d death/MI, it emerged as a
significant independent predictor of long-term death even in the presence of CRP. 
1042-79 Impact of Altered Expression Balance of Matrix 
Metalloproteinases and Tissue Inhibitor of 
Metalloproteinases Genes on Coronary Plaque Rupture: 
Results From Quantitative Tissue Analysis Using Real-
Time Reverse Transcriptase-Polymerase Chain 
Reaction Method
Shuichiro Higo, Shinsuke Nanto, Takeo Higashikata, Hatsue Ishibashi-Ueda, Aiji 
Sakamoto, Hitonobu Tomoike, Masakazu Yamagishi, Kansai Rosai Hospital, Amagasaki, 
Japan, National Cardiovascular Center, Suita, Japan
Background:Previous immunohistochemical studies demonstrated overexpression of
matrix metalloproteinases (MMPs) at the ruptured coronary sites in acute coronary syn-
drome. However, few data exist regarding quantitative analysis of gene expression of
MMPs and their inhibitors, tissue inhibitors of metalloproteinases (TIMPs), in human cor-
onary plaque. Therefore, gene expression of MMPs and TIMPs was quantitatively deter-
mined by real-time RT-PCR.
Method and Results:Tissue samples of the coronary plaque were obtained from 28 cor-
onary patients underwent directional atherectomy. Amounts of the cDNAs for MMP-1, 2,
3 and 9, and TIMP-1, 2, 3 in each cDNA mixture were determined by real-time RT-PCR
method, and normalized with glutaraldehyde 3-dehydrogenase as a reference gene. In
tissue samples from 8 patients with unstable disease. the gene for MMP-9 (5.00 + 1.57)
was significantly augmented to express than those from 20 patients with stable patients
(1.97 + 1.14, p<0.05). There were no statistical significance in MMP-1 (0.41 + 0.19 Ver-
sus 0.34 + 0.10), MMP-2 (2.04 + 0.34 Versus1.85 + 0.22) and MMP-3 (1.36 + 1.06 Ver-
sus 0.28 + 0.08) gene expression. Although the expression levels of TIMP-1, TIMP-2 and
TIMP-3 genes tended higher in unstable (30.19 +5 .11, 4.45 + 0.89 and 6.85 + 2.14) than
that in stable patients (26.33 + 6.24, 3.75 + 1.06 and 4.68 + 1.69), the ratios of MMP-9/
Table
Mortality 
(%)
Urinary protein 
(mg/24h)
LVEDP (mm 
Hg)
PRA (ng Ang1/
mL/h)
QUI week 35 11 9.5±0.9 10±2 192±27
QUI-HCT week 35 0* 7.4±0.5* 7±2 100±19*
QUI week 62 23 9.5±0.6 12±3 73±9
QUI-HCT week 62 22 8.0±0.6 12±3 65±6
